CollPlant Biotechnologies (CLGN) Stock Chart & Stock Price History → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free CLGN Stock Alerts $5.89 +0.53 (+9.89%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media CollPlant Biotechnologies Stock Price Performance5 Day Performance+13.27%1 Month Performance+12.40%3 Month Performance+17.80%6 Month Performance+10.71%Year-To-Date Performance-7.82%1 Year Performance-15.86% Receive CLGN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CollPlant Biotechnologies and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. CLGN Stock Chart for Friday, April, 26, 2024 CLGN Chart by TradingView CollPlant Biotechnologies Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$5.36$5.89+9.89%$5.89$5.425,873 shs$67.44 million04/25/2024$5.41$5.36-0.92%$5.53$5.325,882 shs$61.39 million04/24/2024$5.40$5.41+0.19%$5.42$5.361,040 shs$61.94 million04/23/2024$5.26$5.40+2.66%$5.44$5.2512,622 shs$61.83 million04/22/2024$5.20$5.26+1.15%$5.27$5.194,270 shs$60.23 million04/19/2024$5.24$5.22-0.38%$5.22$5.201,228 shs$59.77 million Get the Latest News and Ratings for CLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CollPlant Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$5.25$5.24-0.19%$5.24$5.108,582 shs$60.00 million04/17/2024$5.14$5.25+2.14%$5.25$5.106,672 shs$60.11 million04/16/2024$5.18$5.14-0.68%$5.19$5.104,396 shs$58.85 million04/15/2024$5.25$5.18-1.33%$5.23$5.156,478 shs$59.25 million04/12/2024$5.22$5.24+0.38%$5.27$5.221,782 shs$60.00 million04/11/2024$5.24$5.22-0.38%$5.30$5.156,362 shs$59.79 million04/10/2024$5.23$5.24+0.29%$5.30$5.207,362 shs$60.00 million04/09/2024$5.11$5.23+2.22%$5.25$5.117,919 shs$59.83 million04/08/2024$5.10$5.11+0.22%$5.19$5.103,085 shs$58.53 million04/05/2024$5.26$5.10-3.04%$5.27$5.103,637 shs$58.40 million04/04/2024$5.46$5.26-3.57%$5.42$5.226,737 shs$60.23 million04/03/2024$5.26$5.46+3.71%$5.46$5.293,855 shs$62.46 million04/02/2024$5.36$5.26-1.87%$5.37$5.261,692 shs$60.23 million04/01/2024$5.35$5.36+0.19%$5.40$5.261,247 shs$61.39 million03/29/2024$5.39$5.35-0.74%$5.47$5.252,648 shs$61.26 million03/28/2024$5.44$5.39-0.92%$5.47$5.252,648 shs$61.72 million03/27/2024$5.24$5.44+3.82%$5.44$5.255,243 shs$62.29 million03/26/2024$5.25$5.24-0.19%$5.45$5.143,062 shs$60.01 million03/25/2024$5.10$5.25+2.94%$5.25$5.0833,005 shs$60.11 million03/22/2024$5.02$5.22+3.98%$5.22$5.10491 shs$59.77 million03/21/2024$5.14$5.02-2.33%$5.16$5.014,805 shs$57.49 million03/20/2024$5.22$5.14-1.53%$5.23$5.144,640 shs$58.85 million03/19/2024$5.10$5.22+2.35%$5.24$5.052,069 shs$59.77 million03/18/2024$5.01$5.10+1.80%$5.10$5.012,549 shs$58.40 million03/15/2024$5.32$5.00-6.02%$5.15$5.002,692 shs$57.25 million03/14/2024$5.17$5.32+2.90%$5.32$5.063,243 shs$60.91 million03/13/2024$5.08$5.17+1.76%$5.22$4.969,163 shs$59.20 million03/12/2024$5.08$5.08+0.05%$5.60$5.083,220 shs$58.17 million03/11/2024$4.90$5.08+3.64%$5.08$5.002,390 shs$58.15 million03/08/2024$5.01$4.90-2.20%$5.01$4.7212,134 shs$56.11 million03/07/2024$4.71$5.01+6.37%$5.20$4.7219,607 shs$57.38 million03/06/2024$5.01$4.71-5.99%$5.09$4.2227,553 shs$53.93 million03/05/2024$5.00$5.01+0.20%$5.13$5.004,304 shs$57.36 million03/04/2024$5.21$5.00-4.03%$5.32$5.0026,731 shs$57.25 millionProtect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late.03/01/2024$5.22$5.21-0.19%$5.67$5.213,083 shs$59.65 million02/29/2024$5.50$5.22-5.09%$5.50$5.199,832 shs$59.77 million02/28/2024$5.59$5.50-1.61%$5.53$5.401,717 shs$62.98 million02/27/2024$5.65$5.59-1.06%$5.67$5.301,952 shs$64.01 million02/26/2024$5.68$5.65-0.53%$5.67$5.352,807 shs$64.69 million02/23/2024$5.37$5.68+5.77%$5.73$5.402,132 shs$62.99 million02/22/2024$5.36$5.37+0.19%$5.49$5.305,458 shs$59.53 million02/21/2024$5.55$5.36-3.42%$5.72$5.3118,857 shs$59.44 million02/20/2024$5.49$5.55+1.09%$5.75$5.3016,147 shs$61.55 million02/19/2024$5.49$5.49$5.72$5.354,800 shs$60.88 million02/16/2024$5.36$5.49+2.43%$5.72$5.354,839 shs$60.88 million02/15/2024$5.44$5.36-1.47%$5.53$5.36973 shs$59.44 million02/14/2024$5.16$5.44+5.43%$5.44$5.371,750 shs$60.33 million02/13/2024$5.40$5.16-4.44%$5.38$5.084,148 shs$57.22 million02/12/2024$5.52$5.40-2.09%$5.58$5.3511,457 shs$59.86 million02/09/2024$5.60$5.51-1.61%$5.60$5.503,089 shs$61.11 million02/08/2024$5.70$5.60-1.75%$5.75$5.2617,781 shs$62.10 million02/07/2024$5.75$5.70-0.87%$5.74$5.5414,903 shs$63.21 million02/06/2024$5.70$5.75+0.88%$5.75$5.659,428 shs$63.77 million02/05/2024$5.80$5.70-1.72%$5.75$5.559,772 shs$63.21 million02/02/2024$5.49$5.80+5.65%$5.80$5.316,450 shs$64.32 million02/01/2024$5.48$5.49+0.18%$5.63$5.347,907 shs$60.88 million01/31/2024$5.25$5.48+4.38%$5.48$5.257,951 shs$60.77 million01/30/2024$5.25$5.25$5.27$5.1616,787 shs$58.22 million01/29/2024$5.00$5.25+5.00%$5.25$5.011,437 shs$58.22 million01/26/2024$5.17$5.00-3.29%$5.28$4.949,869 shs$55.45 million01/25/2024$5.44$5.17-4.96%$5.32$5.0012,060 shs$57.34 million Related Companies: Vicarious Surgical Stock Chart Milestone Scientific Stock Chart ReWalk Robotics Stock Chart Nutriband Stock Chart Envoy Medical Stock Chart Inogen Stock Chart Enzo Biochem Stock Chart IceCure Medical Stock Chart Viveon Health Acquisition Stock Chart SEP Acquisition Stock Chart Receive CLGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CollPlant Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CLGN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CollPlant Biotechnologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.